Literature DB >> 24345912

Effect of chronic ethanol consumption in female rats subjected to experimental sepsis.

C L Castro1, A S Aguiar-Nemer2, H C Castro-Faria-Neto3, F R Barros1, E M S Rocha4, V A Silva-Fonseca5.   

Abstract

The objective of this research was to evaluate the interference of ethanol consumption by female rats with cytokines involved in the sepsis process and its correlation with mortality, the main outcome of sepsis. Female Wistar rats in estrus phase were evaluated in three experiments. Experiment 1 (n=40) was performed to determine survival rates. Experiment 2 (n=69) was designed for biochemical analysis, measurement of cytokine and estrogen levels before and after sepsis, and experiment 3 (n=10) was performed to evaluate bacterial growth by colony counts of peritoneal fluid. In all experiments, treated animals were exposed to a 10% ethanol/water solution (v/v) as the single drinking source, while untreated animals were given tap water. After 4 weeks, sepsis was induced in the rats by ip injection of feces. In experiment 1, mortality in ethanol-exposed animals was delayed compared with those that drank water (48 h; P=0.0001). Experiment 2 showed increased tumor necrosis factor alpha (TNF-α) and decreased interleukin-6 (IL-6) and macrophage migration inhibitory factor in septic animals exposed to ethanol compared to septic animals not exposed. Sepsis also increased TNF-α and IL-6 levels in both ethanol- and water-exposed groups. Biochemical analysis showed higher creatinine, alanine aminotransferase and aspartate aminotransferase and decreased glucose levels in septic animals that were exposed to ethanol. In experiment 3, septic animals exposed to ethanol showed decreased numbers of colony-forming units than septic animals exposed to water. These results suggest that ethanol consumption delays the mortality of female rats in estrus phase after sepsis induction. Female characteristics, most probably sex hormones, may be involved in cytokine expression.

Entities:  

Year:  2013        PMID: 24345912      PMCID: PMC3935275          DOI: 10.1590/1414-431X20133189

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


Introduction

Ethanol is known to have a variety of effects on immune function, including decreased lymphocyte responsiveness to mitogen, decreased neutrophil chemotactic and phagocytic functions, and alteration of cytokine production by lymphocytes and macrophages (1). Extensive evidence indicates that ethanol consumption affects human health. These effects are complex and depend on many factors, such as patterns of drinking (chronic or acute), the amount of consumed ethanol (moderate or excessive), the body organ or system and the gender of the user. Chronic alcohol abuse, defined as 120-150 g or ≥8 drinks per day, has been associated with immunosuppression and increased morbidity and mortality. The lowest death rate correlates with low to moderate amounts of ethanol, at 15-45 g or 1-3 drinks per day, while abstaining from ethanol or excessive drinking are both associated with higher mortality (2). An increased predisposition to infection among patients with problems of alcohol use may mediate an association with sepsis (3). Despite recent improvements in intensive care and antibiotics, sepsis remains associated with a high mortality rate, possibly because of its diverse etiology and comorbidities. Sepsis is defined according to the clinical signs of a systemic response to infection. The term “severe sepsis” refers to the sepsis-associated failure of multiple organ systems (4). Between 20 and 50% of patients with sepsis die and, in those who survive, sepsis is associated with reduced quality of life (5). Extensive efforts have been devoted to the prediction of mortality during sepsis. The initial hyperinflammatory response to bacteria can lead to septic shock. Risk factors for septic shock include advanced age, diminished physical performance, presence of pathogens, low platelet count, leukocytosis or leukopenia, low albumin concentration, increased levels of liver enzymes, and high plasma creatinine concentrations, which are very common in alcoholics. Septic shock is characterized by an over-production of cytokines, as shown in numerous clinical trials conducted with agents that block the inflammatory cascade. However, death from sepsis is not always attributable to an over-stimulated immune system. Several observations demonstrated that as sepsis persists, there is a shift toward an anti-inflammatory immunosuppressive state (6). It is increasingly recognized that gender may be a major factor in the outcome of patients after stress conditions such as trauma and sepsis. Findings from both clinical studies and experimental animal models suggest that women are more tolerant to major injuries than men (7-10) and sex steroids seem to be responsible for this gender-specific outcome (11). However, medical literature in female subjects is scarce, probably because of hormonal alterations and consequent variability. As for the effects of ethanol, a few studies suggest that it would significantly alter sex hormone levels and function in exposed subjects (12). The hypothesis of the present study was that ethanol interferes with the course of sepsis in female rats. Cytokines involved in the sepsis process and the interference of ethanol consumption on their level were studied, and their correlation with mortality, the main outcome of sepsis, was evaluated in female rats.

Material and Methods

Animals

The study was approved by the Animal Research Ethics Committe of Universidade Federal Fluminense (#00115-09). Female Wistar (Rattus novergicus), 4 to 6 weeks old (150-170 g), were used. The animals were maintained on 12-h light-dark cycles with free access to food and liquid (water or ethanol). Animals exposed to ethanol received 10% ethanol/water solution (v/v; 10 mL ethanol+90 mL water) daily for 4 weeks. Liquid and food consumption as well as body weight were measured every 48 h.

Septic procedure

After 4 weeks of ethanol consumption, samples of vaginal cells were taken before initiation of the sepsis procedure and cardiac puncture. All female rats had pipettes with saline solution inserted 4 mm into the vagina. The pipettes were then pressed on microscope slides, and the cells were stained with methylene blue and examined under light microscopy. Estrus phases were determined by relative cell densities as follows. Diestrus was identified by predominance of small cells (leukocytes) as well as larger, round, nucleated epithelial cells and cornified epithelial cells; diestrus II by leukocytes and round, nucleated epithelial cells with few cornified epithelial cells; proestrus by round, nucleated epithelial cells; and estrus by cornified epithelial cells. Sepsis was induced in animals in the estrus phase by injecting fresh feces in the peritoneum. To prepare the feces solution, random animals were sacrificed for removal of feces from the large intestine. The material was collected in conical polypropylene centrifuge tubes with a capacity of 50 mL. Then, saline was added to feces dilution (15 mL saline to each 5000 mL feces) and the final solution was centrifuged at 215 g for 5 min. The supernatant was removed and injected intraperitoneally (ip) at 1 mL/100 g body weight (13). Animals that drank water underwent the same technique described above after 4 weeks.

Experiment 1: subchronic ethanol consumption and survival analysis

In experiment 1, the animals (150-169 g) were randomly divided into two groups. A sepsis group consisting of 20 animals receiving water, and an ethanol sepsis group consisting of 20 animals receiving a 10% ethanol/water solution. Four weeks later, polymicrobial sepsis was induced in both groups of animals in estrus phase. Eight hours after sepsis induction, when the animals showed clinical signals of sepsis (ruffled fur, hypothermia, lacrimation, lethargy), a combination of the antibiotics imipenem and cilastatin (8 mg/kg) was injected subcutaneously to increase the survival rate. Animals were observed after septic induction every 8 h for detection of mortality.

Experiment 2: subchronic ethanol consumption and immune response in sepsis

In experiment 2, rats (4 to 6 weeks old and weighing 150-160 g) were used to evaluate the effects of ethanol consumption on biochemical parameters, cytokine and estrogen levels after sepsis induction. The animals were randomly assigned to one of four groups. Controls received water and were challenged with ip saline (n=12). The septic group received water and was challenged with ip feces solution (n=20). Two of the groups received 10% ethanol/water solution. The ethanol group was challenged with saline (n=12), and the ethanol septic group was challenged with ip feces solution (n=25). Four weeks later, the septic and ethanol septic groups underwent sepsis induction while the control and ethanol groups received normal saline ip. Whole blood was obtained by cardiac puncture 8 h after sepsis induction or saline injection in animals in estrus phase.

Serum collection and storage

For the cardiac puncture procedure, rats were anesthetized with 112.5 mg/kg ketamine and 7.5 mg/kg xylazine ip. Serum was separated by centrifugation at 1700 g and samples were immediately frozen and stored (-80°C) until assayed.

Biochemical analysis

Biochemical tests were performed on a semiautomatic spectrophotometer brand model BYO2000 (Bioplus, Brazil). The following biochemical parameters were analyzed: alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin, creatinine, glucose, total protein, and urea. Serum ALT and AST were assayed by a kinetic method and serum creatinine, albumin, glucose, total protein, and urea by a colorimetric method. All tests used diagnostic reagent kits from Labtest Ltd., Brazil.

Cytokines and estrogen analysis

Pro-inflammatory [TNF-α, IL-6 and macrophage migration inhibitory factor (MIF)] and anti-inflammatory (TGF-β, IL-10 and IL-13) cytokines and female sex steroid hormone 17β-estradiol (E2) levels present in blood serum were quantified by ELISA (DuoSet Kit/R&D Systems, USA) according to manufacturer's specifications. Data were analyzed using the SoftMax Pro 5 program (USA).

Experiment 3: estimation of the number of bacterial colonies in peritoneal fluid

Peritoneal fluid was obtained from 10 randomly chosen rats by washing the peritoneal cavity with 4 mL 0.9% saline. One animal was from the control group and 1 from the ethanol group; 4 animals were from the septic group and 4 from the ethanol septic group. Animals had ad libitum access to liquids and food for 4 weeks prior to induction of sepsis in the septic and ethanol septic groups as described above. For the analysis of bacterial growth, trypticase soy agar Petri plates were used. Serial 10-fold dilutions were prepared at 10−2 and 10−4. Plates were incubated at 37°C for 24 h and bacterial growth was evaluated from colony counts using the formula colony-forming units (CFU)=colonies×dilution/10 µL.

Statistical analysis

Data were analyzed with the GraphPad Prism 4.0 (USA) statistical program and are reported as means±SE. One-way ANOVA followed by the Student t-test were used to compare body weight data. Log rank was used to compare survival proportions and Kruskal-Wallis and Mann-Whitney tests for comparisons of the cytokines, estrogen and biochemistry groups. A P value ≤0.05 was considered to be significant.

Results

Experiment 1: ethanol consumption and survival analysis

Daily ethanol consumption averaged 10.9±1.9 g/kg in the exposed groups. We did not observe differences in body weight between the groups (control: 203.3 ± 22.4 g; ethanol: 181.2±23.9; septic: 201.4±23.8 g; ethanol septic: 184.4±23.7 g, P>0.05). Twenty-four hours after sepsis induction, 13 animals in the septic group (65%) and 2 animals in the ethanol septic group (13%) had already died. After 48 h, the mortality rate was 17 animals in the septic group (85%) and 14 animals in the ethanol septic group (70%; Figure 1). The difference in the mortality rates in these groups reached statistical significance at 48 h (P=0.0001, log rank test).
Figure 1

Ethanol consumption protects female rats against sepsis. The septic group (n=20) received water and the ethanol septic group (n=20) received 10% ethanol solution for 4 weeks. Animals in estrus phase were challenged with feces injected intraperitoneally at 48 h. P=0.0001, log rank test.

Experiment 2: immune response in sepsis

Cytokines

Analysis of pro- and anti-inflammatory serum cytokines 8 h after sepsis induction demonstrated that sepsis increased the levels of TNF-α and IL-6. There was also a significant increase in the levels of the pro-inflammatory cytokine TNF-α in the ethanol septic group compared with the septic group (P=0.02) and a decrease in the levels of the proinflammatory cytokines IL-6 and MIF in the ethanol septic group compared with the septic group, demonstrating that ethanol consumption altered the pattern of cytokine production after sepsis. There was no difference in IL-10 levels in the septic and the ethanol septic groups. No differences were observed in the levels of the anti-inflammatory cytokines TGF-β and IL-13 in the groups (Figure 2).
Figure 2

Ethanol consumption alters pro-inflammatory cytokine response after sepsis. Ethanol consumption did not interfere with anti-inflammatory cytokine response after sepsis. Control (n=12) and septic (n=20) groups received water, and ethanol (n=12) and ethanol septic (n=25) groups received 10% ethanol solution for 4 weeks. Septic and ethanol septic groups underwent septic procedure while control and ethanol groups received normal saline injected intraperitoneally. Whole blood was obtained by cardiac puncture 8 h after sepsis induction or saline injection in animals in estrus phase. Data are reported as means±SE from at least 12 animals. Tumor necrosis alpha (TNF-α): *P=0.02; **P=0.004; ***P<0.0001. Macrophage migration inhibitor factor (MIF): *P=0.03. Interleukin 6 (IL-6): *P=0.04; **P=0.003; ***P=0.0005 (Mann-Whitney test). TNF-α: P<0.0001; IL-6: P<0.0001; MIF: P=0.041 (Kruskal-Wallis). No significant differences were found by Kruskal-Wallis (IL-10) and Mann-Whitney [transforming growth factor beta (TGF-β); IL-13] tests.

Liver function was evaluated by ALT and AST levels. The ethanol septic group showed higher levels of these enzymes. The differences in ALT levels in the ethanol septic and the ethanol groups and AST levels in the ethanol septic and the septic groups were statistically significant (Figure 3). Creatinine analysis showed an increase in the ethanol septic group compared with the ethanol and the septic groups. There was also a significant difference between hypoglycemia in animals with sepsis that consumed ethanol compared to the ethanol and the septic groups. No differences in proteins, urea and albumin levels were noted between the groups (Figure 4).
Figure 3

Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were increased in animals exposed to ethanol and subjected to sepsis. Control (n=12) and septic (n=20) groups received water, and ethanol (n=12) and ethanol septic (n=25) groups received 10% ethanol solution for 4 weeks. Septic and ethanol septic groups underwent septic procedure while control and ethanol groups received normal saline injected intraperitoneally. Whole blood was obtained by cardiac puncture 8 h after sepsis induction or saline injection in animals in estrus phase. Data are reported as means±SE for at least 12 animals. ALT: **P=0.007. AST: *P=0.03 (Mann-Whitney test).

Figure 4

Levels of glucose and creatinine were altered in animals exposed to ethanol and subjected to sepsis. Control (n=12) and septic (n=20) groups received water, and ethanol (n=12), and ethanol septic (n=25) groups received 10% ethanol solution for 4 weeks. Septic and ethanol septic groups underwent septic procedure while control and ethanol groups received normal saline injected intraperitoneally. Whole blood was obtained by cardiac puncture 8 h after sepsis induction or saline injection in animals in estrus phase. Data are reported as means±SE for at least 12 animals. Glucose: **P=0.008; *P=0.04. Creatinine: **P=0.01; *P=0.03 (Mann-Whitney test). There were no significant differences in proteins, urea and albumin levels between groups.

As expected, there was no bacterial growth in the control and the ethanol groups. In all animals subjected to sepsis, there was a positive detection of growth. The bacterial colonies in both groups were too numerous to count at a dilution of 10−2. At a dilution of 10−4, the median numbers of colonies were 35,000 CFU for control septic animals and 5000 CFU for ethanol septic animals.

Discussion

This study suggests that ethanol consumption delays the mortality of female rats after sepsis induction. The survival advantage was associated with increases in the pro-inflammatory cytokine TNF-α and decreases in IL-6 and MIF levels. However, it was not associated with differences in the anti-inflammatory cytokines IL-10, TGF-β and IL-13. We have reported on the same sepsis induction model in male rats exposed to 10% ethanol/water as the only source of liquid for 4 weeks (13). Mortality was directly correlated to ethanol consumption, that is, rats that voluntarily consumed more ethanol (>11 g/kg) died earlier. In the present study, mean consumption of ethanol was 10.9 g/kg, and yet the survival rate differed from that found in males. Taken together, these data suggest a possible protective role of the female hormone profile in the sepsis process. Acute ethanol intake plus trauma can decrease TNF-α production during the very early postinjury (0-3 days) period. However, TNF-α production by ethanol-exposed patients became hyperelevated late postinjury (>9 days). Elevated TNF-α levels such as these may contribute to post-trauma immunosuppression after acute ethanol use (14). Although pro-inflammatory cytokines are considered to be dangerous, causing organ failure and apoptosis of immune system cells (15), they also have essential beneficial effects. Blocking TNF-α worsens survival from peritonitis in animal models and clinical studies (16,17). The role of TNF-α in combating infection has been underscored by the finding that sepsis and other infectious complications have been observed in patients with rheumatoid arthritis treated with TNF-α antagonists (18). Furthermore, repetitive ip injection of sublethal doses of recombinant human TNF-α in rats undergoing cecal ligation and puncture (CLP) 1 day after the treatment period resulted in a significant reduction in mortality compared with control rats previously unexposed to TNF-α (19). In this study, the TNF-α increase in the ethanol septic group compared with the septic group confirms the pro-inflammatory beneficial role of TNF-α in the acute phase of sepsis. Multiple studies have demonstrated that elevated serum IL-6 correlates with increased mortality (20,21). In the CLP model of sepsis, animals with the highest mortality have the highest levels of IL-6 (22). In rodent models, the association between increased IL-6 levels after burn, sepsis or trauma-hemorrhage and cardiac dysfunction combined with poor outcome has also been identified (23). Our results demonstrated that animals that had ethanol consumption and sepsis had lower IL-6 and MIF levels. These results can be linked to their improved survival, especially because MIF, similar to IL-6, also contributes to the pathogenesis of sepsis (24). Blockade of MIF with specific neutralizing monoclonal antibodies protected mice from lethal sepsis induced by CLP (survival was 81% in antibody-treated mice and 31% in control mice). This treatment was successful even when antibodies were administered 4.5 h after CLP (survival was 61% in antibody-treated mice and 5% in control mice) (25). In male rats treated using the same experimental model, sepsis significantly increased levels of the pro-inflammatory cytokines IL-6 and TNF-α. No significant differences were found in IL-4 and IL-13. Ethanol significantly decreased the effect of sepsis in the levels of IL-6 and TNF-α (13). Biochemical parameters demonstrated that rats in the ethanol septic group had lower glucose levels than those in the septic and ethanol groups. Ethanol can cause hypoglycemia by inhibiting gluconeogenesis, reducing glucose synthesis, and impairing its transport to the liver perivascular space (26). Hypoglycemia in sepsis may have occurred as a result of lethargy of the animals, leading to lower water and food consumption, and may have been one of the causes of the decrease in prolonged survival in ethanol septic rats at 48 h compared with 24 h. Mortality from sepsis is increased when complicated by acute kidney injury (27). However, the association between ethanol consumption and renal function is poorly understood. There is evidence that chronic ethanol consumption may cause direct damage to the kidneys (28). In this study, increased creatinine levels in sepsis shows that there was a decrease in glomerular filtration, probably caused by ethanol. Similarly, liver injury can increase the risk of septic shock, which is very common in alcoholics (29). The higher levels of ALT in the ethanol sepsis group compared to the ethanol group and the increased levels of AST in the ethanol sepsis group compared to the sepsis group are in accordance with other studies. However, the liver injury indicated by the AST and ALT levels was probably not enough to increase mortality in this group of animals. Regarding the female hormones, chronic exposure to ethanol alters the production of estrogen and hence ethanol's effects on immunity could involve an indirect mechanism in which ethanol alters hormone levels and, in turn, the hormones regulate immune responses. There is evidence of a protective role of estrogen in trauma and sepsis. In male rodents, administration of 17β-estradiol (estrogen) after trauma-hemorrhage normalized the enhanced pro-inflammatory cytokine release from several cell types such as Kupffer cells and cardiomyocytes. Estrogen treatment after trauma-hemorrhage was also able to restore cardiac function, presumably because of the normalization of IL-6 release (23). The increase in TNF-α production, detected in our study, could explain the decreased CFU numbers observed in experiment 3 in the ethanol septic group, and is probably an additional factor increasing survival rates in this group of animals. Macrophages are the first line of defense against bacterial colonization of ascites fluid (30). The increase in TNF-α production detected in our study may be related to the activation of macrophages and consequent early bacterial clearance. This rationale could explain the observed mortality delay in the ethanol septic group. However, this mechanism was not able to prevent the effects of other cytokines on multiple organ failure. We, therefore, conclude that delayed mortality associated with ethanol consumption in the ethanol sepsis group could be attributed to female characteristics, most probably sex hormones. However, we cannot clarify whether the cytokine modulation observed in this study, which also exerted a protective role in sepsis, was due directly to ethanol consumption or to increased levels of sex hormones. Further investigation with estrogen replacement in ovariectomized female animals exposed to ethanol could be useful to evaluate this issue.
  30 in total

1.  Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.

Authors:  R S Hotchkiss; K W Tinsley; P E Swanson; R E Schmieg; J J Hui; K C Chang; D F Osborne; B D Freeman; J P Cobb; T G Buchman; I E Karl
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

2.  Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Authors:  T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

Review 3.  Gonadal steroids and immunity.

Authors:  N J Olsen; W J Kovacs
Journal:  Endocr Rev       Date:  1996-08       Impact factor: 19.871

4.  Contributions of dietary carbohydrate and ethanol to alterations in liver glycogen levels and glycolytic activity.

Authors:  C G Van Horn; C C Cunningham
Journal:  Alcohol       Date:  1999-10       Impact factor: 2.405

5.  Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice.

Authors:  B Echtenacher; K Weigl; N Lehn; D N Männel
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

6.  Septic shock in bacteremic patients: risk factors, features and prognosis.

Authors:  L Leibovici; M Drucker; H Konigsberger; Z Samra; S Harrari; S Ashkenazi; S D Pitlik
Journal:  Scand J Infect Dis       Date:  1997

7.  Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function.

Authors:  Shaolong Yang; Rui Zheng; Shunhua Hu; Yuchen Ma; Mashkoor A Choudhry; Joseph L Messina; Loring W Rue; Kirby I Bland; Irshad H Chaudry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11       Impact factor: 4.733

Review 8.  Exposure-dependent effects of ethanol on the innate immune system.

Authors:  Joanna Goral; John Karavitis; Elizabeth J Kovacs
Journal:  Alcohol       Date:  2008-04-14       Impact factor: 2.405

9.  Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.

Authors:  Rosa C S Vianna; Rachel N Gomes; Fernando A Bozza; Rodrigo T Amâncio; Patrícia T Bozza; Cid M N David; Hugo C Castro-Faria-Neto
Journal:  Shock       Date:  2004-02       Impact factor: 3.454

Review 10.  Effect of estradiol administration on splanchnic perfusion after trauma-hemorrhage and sepsis.

Authors:  Yukihiro Yokoyama; Martin G Schwacha; Kirby I Bland; Irshad H Chaudry
Journal:  Curr Opin Crit Care       Date:  2003-04       Impact factor: 3.687

View more
  1 in total

1.  Chronic Alcohol Ingestion Worsens Survival and Alters Gut Epithelial Apoptosis and CD8+ T Cell Function After Pseudomonas Aeruginosa Pneumonia-Induced Sepsis.

Authors:  Nathan J Klingensmith; Katherine T Fay; John D Lyons; Ching-Wen Chen; Shunsuke Otani; Zhe Liang; Deena B Chihade; Eileen M Burd; Mandy L Ford; Craig M Coopersmith
Journal:  Shock       Date:  2019-04       Impact factor: 3.454

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.